Financials Excelsior Medical Co., Ltd.

Equities

4104

TW0004104005

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E. 06:00:00 2024-05-07 pm EDT 5-day change 1st Jan Change
91.8 TWD -0.54% Intraday chart for Excelsior Medical Co., Ltd. +0.77% +3.85%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 5,895 6,907 7,918 8,130 10,019 13,757
Enterprise Value (EV) 1 3,581 4,957 5,076 5,121 7,599 11,793
P/E ratio 13.1 x 13.5 x 13.9 x 13.5 x 15.1 x 18.5 x
Yield 6.52% 6.12% 6.24% 6.08% 5.4% 4.3%
Capitalization / Revenue 0.93 x 1.07 x 1.19 x 1.24 x 1.39 x 1.67 x
EV / Revenue 0.56 x 0.77 x 0.76 x 0.78 x 1.06 x 1.43 x
EV / EBITDA 6.94 x 9.11 x 8.24 x 7.13 x 10.2 x 13.6 x
EV / FCF -25.2 x 4 x 7.08 x 7.47 x 19.8 x -139 x
FCF Yield -3.96% 25% 14.1% 13.4% 5.06% -0.72%
Price to Book 0.87 x 0.99 x 1.04 x 1.05 x 1.22 x 1.6 x
Nbr of stocks (in thousands) 141,284 141,284 155,617 155,617 155,617 155,617
Reference price 2 41.72 48.89 50.88 52.24 64.38 88.40
Announcement Date 3/29/19 3/26/20 3/26/21 3/21/22 3/23/23 3/14/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 6,345 6,457 6,675 6,573 7,187 8,233
EBITDA 1 515.7 544 616.3 717.7 741.4 866.1
EBIT 1 438.1 464 529.1 595 606.6 702.9
Operating Margin 6.9% 7.19% 7.93% 9.05% 8.44% 8.54%
Earnings before Tax (EBT) 1 648.5 746.8 829.4 873.7 963.7 1,144
Net income 1 451.6 514.8 571.7 607.1 667.5 746.6
Net margin 7.12% 7.97% 8.56% 9.24% 9.29% 9.07%
EPS 2 3.178 3.619 3.664 3.882 4.267 4.780
Free Cash Flow 1 -141.9 1,241 717.5 685.1 384.7 -84.71
FCF margin -2.24% 19.21% 10.75% 10.42% 5.35% -1.03%
FCF Conversion (EBITDA) - 228.07% 116.41% 95.46% 51.89% -
FCF Conversion (Net income) - 241.03% 125.51% 112.84% 57.64% -
Dividend per Share 2 2.721 2.993 3.175 3.175 3.476 3.800
Announcement Date 3/29/19 3/26/20 3/26/21 3/21/22 3/23/23 3/14/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2023 Q1 2023 Q2 2023 Q3
Net sales 1 1,708 1,674 2,006 2,022 2,020
EBITDA - - - - -
EBIT 1 165 143.7 - 179.4 156.3
Operating Margin 9.66% 8.58% - 8.87% 7.74%
Earnings before Tax (EBT) - - - - -
Net income - - - - -
Net margin - - - - -
EPS - - - - -
Dividend per Share - - - - -
Announcement Date 5/12/22 8/11/22 5/12/23 8/11/23 11/10/23
1TWD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 2,314 1,950 2,842 3,010 2,420 1,964
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -142 1,241 717 685 385 -84.7
ROE (net income / shareholders' equity) 6.7% 7.33% 7.35% 7.48% 7.84% 8.7%
ROA (Net income/ Total Assets) 1.89% 2.09% 2.38% 2.56% 2.4% 2.54%
Assets 1 23,857 24,624 24,005 23,762 27,805 29,371
Book Value Per Share 2 48.20 49.20 48.80 49.70 52.70 55.30
Cash Flow per Share 2 21.90 20.00 16.80 19.70 16.10 16.80
Capex 1 33 51.3 30.7 165 172 126
Capex / Sales 0.52% 0.79% 0.46% 2.51% 2.39% 1.53%
Announcement Date 3/29/19 3/26/20 3/26/21 3/21/22 3/23/23 3/14/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 4104 Stock
  4. Financials Excelsior Medical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW